Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(3.16)
# 1,166
Out of 4,412 analysts
422
Total ratings
35.35%
Success rate
3.42%
Average return
Main Sectors:
55 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSTA Lisata Therapeutics | Reiterates: Buy | $15 | $2.66 | +463.91% | 8 | Apr 26, 2024 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $40 | $5.15 | +676.70% | 8 | Apr 25, 2024 | |
| XOMA XOMA Corporation | Reiterates: Buy | $74 | $25.36 | +191.80% | 10 | Apr 25, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $90 | $68.86 | +30.70% | 13 | Apr 25, 2024 | |
| ATXS Astria Therapeutics | Maintains: Buy | $18 → $16 | $9.17 | +74.48% | 9 | Apr 23, 2024 | |
| KRYS Krystal Biotech | Reiterates: Buy | $200 | $155.68 | +28.47% | 14 | Apr 22, 2024 | |
| KURA Kura Oncology | Reiterates: Buy | $32 | $19.00 | +68.42% | 10 | Apr 22, 2024 | |
| PHGE BiomX | Reiterates: Buy | $2 | $0.34 | +495.24% | 7 | Apr 22, 2024 | |
| BLRX BioLineRx | Reiterates: Buy | $21 | $0.58 | +3,550.27% | 6 | Apr 17, 2024 | |
| CLDX Celldex Therapeutics | Reiterates: Buy | $80 | $36.26 | +120.63% | 16 | Apr 17, 2024 | |
| CLNN Clene | Reiterates: Buy | $7 | $0.35 | +1,920.20% | 18 | Apr 17, 2024 | |
| CMPX Compass Therapeutics | Reiterates: Buy | $10 | $1.48 | +575.68% | 6 | Apr 16, 2024 | |
| PBLA Panbela Therapeutics | Maintains: Buy | $16 → $5 | $0.44 | +1,036.36% | 8 | Apr 2, 2024 | |
| BMEA Biomea Fusion | Reiterates: Buy | $50 | $10.47 | +377.55% | 12 | Apr 1, 2024 | |
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $50 | $6.56 | +662.20% | 13 | Apr 1, 2024 | |
| PDSB PDS Biotechnology | Maintains: Buy | $21 | $3.26 | +544.17% | 16 | Mar 27, 2024 | |
| APTO Aptose Biosciences | Maintains: Buy | $23 | $1.16 | +1,882.76% | 9 | Mar 27, 2024 | |
| APRE Aprea Therapeutics | Maintains: Buy | $20 | $5.35 | +273.83% | 6 | Mar 26, 2024 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $1.99 | +704.02% | 9 | Mar 25, 2024 | |
| CKPT Checkpoint Therapeutics | Reiterates: Buy | $34 | $1.42 | +2,294.37% | 7 | Mar 22, 2024 | |
| ARMP Armata Pharmaceuticals | Maintains: Buy | $7 | $2.53 | +176.59% | 8 | Mar 22, 2024 | |
| BNOX Bionomics | Reiterates: Buy | $8 | $0.97 | +727.90% | 5 | Mar 21, 2024 | |
| OABI OmniAb | Reiterates: Buy | $11 | $4.43 | +148.31% | 4 | Mar 21, 2024 | |
| ALPN Alpine Immune Sciences | Maintains: Buy | $50 | $64.62 | -22.62% | 7 | Mar 21, 2024 | |
| TPST Tempest Therapeutics | Reiterates: Buy | $47 | $3.48 | +1,250.57% | 11 | Mar 20, 2024 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $18 | $4.22 | +326.54% | 6 | Mar 19, 2024 | |
| LIFE aTyr Pharma | Reiterates: Buy | $35 | $1.60 | +2,094.36% | 13 | Mar 15, 2024 | |
| PHAR Pharming Group | Reiterates: Buy | $37 | $10.45 | +254.07% | 5 | Mar 14, 2024 | |
| CVKD Cadrenal Therapeutics | Reiterates: Buy | $3 | $0.42 | +608.22% | 2 | Mar 14, 2024 | |
| CALC CalciMedica | Reiterates: Buy | $20 | $5.29 | +278.07% | 3 | Mar 13, 2024 | |
| LCTX Lineage Cell Therapeutics | Reiterates: Buy | $7 | $1.11 | +530.63% | 6 | Mar 8, 2024 | |
| RIGL Rigel Pharmaceuticals | Reiterates: Buy | $15 | $1.10 | +1,263.64% | 13 | Mar 6, 2024 | |
| IOVA Iovance Biotherapeutics | Reiterates: Buy | $32 | $11.54 | +177.30% | 17 | Mar 4, 2024 | |
| STTK Shattuck Labs | Reiterates: Buy | $28 | $9.78 | +186.30% | 10 | Mar 1, 2024 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $144 | $70.37 | +104.63% | 11 | Feb 29, 2024 | |
| VYNE VYNE Therapeutics | Reiterates: Buy | $5.75 | $2.47 | +132.79% | 9 | Feb 29, 2024 | |
| CYTK Cytokinetics | Reiterates: Buy | $94 | $64.80 | +45.06% | 17 | Feb 28, 2024 | |
| PTN Palatin Technologies | Maintains: Buy | $70 → $17 | $1.72 | +888.37% | 11 | Feb 28, 2024 | |
| BIOR Biora Therapeutics | Reiterates: Buy | $50 | $0.61 | +8,137.23% | 6 | Jan 2, 2024 | |
| BCDA BioCardia | Reiterates: Buy | $4 | $0.37 | +986.96% | 9 | Nov 14, 2023 | |
| NVCT Nuvectis Pharma | Reiterates: Buy | $21 | $6.51 | +222.58% | 5 | Sep 15, 2023 | |
| BPTS Biophytis | Reiterates: Buy | $15 | $8.22 | +82.48% | 5 | Aug 16, 2023 | |
| MBIO Mustang Bio | Reiterates: Buy | $25 | $0.35 | +7,034.70% | 5 | Aug 16, 2023 | |
| BCEL Atreca | Downgrades: Neutral | n/a | $0.09 | - | 6 | Aug 11, 2023 | |
| XBIO Xenetic Biosciences | Downgrades: Neutral | n/a | $3.78 | - | 3 | May 16, 2023 | |
| GNTA Genenta Science | Reiterates: Buy | $25 | $2.91 | +757.87% | 2 | Feb 8, 2023 | |
| BYSI BeyondSpring | Downgrades: Neutral | n/a | $2.27 | - | 4 | Dec 1, 2021 | |
| EPIX ESSA Pharma | Maintains: Buy | n/a | $6.12 | - | 3 | Feb 25, 2021 | |
| SSKN STRATA Skin Sciences | Upgrades: Buy | n/a | $0.53 | - | 2 | Nov 3, 2020 | |
| CDMO Avid Bioservices | Reiterates: Buy | n/a | $7.32 | - | 2 | Mar 11, 2020 | |
| SNGX Soligenix | Downgrades: Neutral | n/a | $0.43 | - | 2 | Jan 31, 2018 | |
| TGTX TG Therapeutics | Assumes: Buy | n/a | $13.91 | - | 2 | Nov 14, 2017 | |
| FBIO Fortress Biotech | Initiates: Buy | n/a | $1.72 | - | 1 | Jul 11, 2017 | |
| PIRS Pieris Pharmaceuticals | Initiates: Buy | $720 | $11.60 | +6,106.90% | 1 | May 30, 2017 | |
| VSTM Verastem | Reiterates: Buy | n/a | $9.22 | - | 1 | Mar 24, 2017 |
Lisata Therapeutics
Apr 26, 2024
Reiterates: Buy
Price Target: $15
Current: $2.66
Upside: +463.91%
Capricor Therapeutics
Apr 25, 2024
Reiterates: Buy
Price Target: $40
Current: $5.15
Upside: +676.70%
XOMA Corporation
Apr 25, 2024
Reiterates: Buy
Price Target: $74
Current: $25.36
Upside: +191.80%
Viking Therapeutics
Apr 25, 2024
Reiterates: Buy
Price Target: $90
Current: $68.86
Upside: +30.70%
Astria Therapeutics
Apr 23, 2024
Maintains: Buy
Price Target: $18 → $16
Current: $9.17
Upside: +74.48%
Krystal Biotech
Apr 22, 2024
Reiterates: Buy
Price Target: $200
Current: $155.68
Upside: +28.47%
Kura Oncology
Apr 22, 2024
Reiterates: Buy
Price Target: $32
Current: $19.00
Upside: +68.42%
BiomX
Apr 22, 2024
Reiterates: Buy
Price Target: $2
Current: $0.34
Upside: +495.24%
BioLineRx
Apr 17, 2024
Reiterates: Buy
Price Target: $21
Current: $0.58
Upside: +3,550.27%
Celldex Therapeutics
Apr 17, 2024
Reiterates: Buy
Price Target: $80
Current: $36.26
Upside: +120.63%
Clene
Apr 17, 2024
Reiterates: Buy
Price Target: $7
Current: $0.35
Upside: +1,920.20%
Compass Therapeutics
Apr 16, 2024
Reiterates: Buy
Price Target: $10
Current: $1.48
Upside: +575.68%
Panbela Therapeutics
Apr 2, 2024
Maintains: Buy
Price Target: $16 → $5
Current: $0.44
Upside: +1,036.36%
Biomea Fusion
Apr 1, 2024
Reiterates: Buy
Price Target: $50
Current: $10.47
Upside: +377.55%
Actinium Pharmaceuticals
Apr 1, 2024
Reiterates: Buy
Price Target: $50
Current: $6.56
Upside: +662.20%
PDS Biotechnology
Mar 27, 2024
Maintains: Buy
Price Target: $21
Current: $3.26
Upside: +544.17%
Aptose Biosciences
Mar 27, 2024
Maintains: Buy
Price Target: $23
Current: $1.16
Upside: +1,882.76%
Aprea Therapeutics
Mar 26, 2024
Maintains: Buy
Price Target: $20
Current: $5.35
Upside: +273.83%
Esperion Therapeutics
Mar 25, 2024
Reiterates: Buy
Price Target: $16
Current: $1.99
Upside: +704.02%
Checkpoint Therapeutics
Mar 22, 2024
Reiterates: Buy
Price Target: $34
Current: $1.42
Upside: +2,294.37%
Armata Pharmaceuticals
Mar 22, 2024
Maintains: Buy
Price Target: $7
Current: $2.53
Upside: +176.59%
Bionomics
Mar 21, 2024
Reiterates: Buy
Price Target: $8
Current: $0.97
Upside: +727.90%
OmniAb
Mar 21, 2024
Reiterates: Buy
Price Target: $11
Current: $4.43
Upside: +148.31%
Alpine Immune Sciences
Mar 21, 2024
Maintains: Buy
Price Target: $50
Current: $64.62
Upside: -22.62%
Tempest Therapeutics
Mar 20, 2024
Reiterates: Buy
Price Target: $47
Current: $3.48
Upside: +1,250.57%
Tenaya Therapeutics
Mar 19, 2024
Reiterates: Buy
Price Target: $18
Current: $4.22
Upside: +326.54%
aTyr Pharma
Mar 15, 2024
Reiterates: Buy
Price Target: $35
Current: $1.60
Upside: +2,094.36%
Pharming Group
Mar 14, 2024
Reiterates: Buy
Price Target: $37
Current: $10.45
Upside: +254.07%
Cadrenal Therapeutics
Mar 14, 2024
Reiterates: Buy
Price Target: $3
Current: $0.42
Upside: +608.22%
CalciMedica
Mar 13, 2024
Reiterates: Buy
Price Target: $20
Current: $5.29
Upside: +278.07%
Lineage Cell Therapeutics
Mar 8, 2024
Reiterates: Buy
Price Target: $7
Current: $1.11
Upside: +530.63%
Rigel Pharmaceuticals
Mar 6, 2024
Reiterates: Buy
Price Target: $15
Current: $1.10
Upside: +1,263.64%
Iovance Biotherapeutics
Mar 4, 2024
Reiterates: Buy
Price Target: $32
Current: $11.54
Upside: +177.30%
Shattuck Labs
Mar 1, 2024
Reiterates: Buy
Price Target: $28
Current: $9.78
Upside: +186.30%
Ligand Pharmaceuticals
Feb 29, 2024
Reiterates: Buy
Price Target: $144
Current: $70.37
Upside: +104.63%
VYNE Therapeutics
Feb 29, 2024
Reiterates: Buy
Price Target: $5.75
Current: $2.47
Upside: +132.79%
Cytokinetics
Feb 28, 2024
Reiterates: Buy
Price Target: $94
Current: $64.80
Upside: +45.06%
Palatin Technologies
Feb 28, 2024
Maintains: Buy
Price Target: $70 → $17
Current: $1.72
Upside: +888.37%
Biora Therapeutics
Jan 2, 2024
Reiterates: Buy
Price Target: $50
Current: $0.61
Upside: +8,137.23%
BioCardia
Nov 14, 2023
Reiterates: Buy
Price Target: $4
Current: $0.37
Upside: +986.96%
Nuvectis Pharma
Sep 15, 2023
Reiterates: Buy
Price Target: $21
Current: $6.51
Upside: +222.58%
Biophytis
Aug 16, 2023
Reiterates: Buy
Price Target: $15
Current: $8.22
Upside: +82.48%
Mustang Bio
Aug 16, 2023
Reiterates: Buy
Price Target: $25
Current: $0.35
Upside: +7,034.70%
Atreca
Aug 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.09
Upside: -
Xenetic Biosciences
May 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.78
Upside: -
Genenta Science
Feb 8, 2023
Reiterates: Buy
Price Target: $25
Current: $2.91
Upside: +757.87%
BeyondSpring
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.27
Upside: -
ESSA Pharma
Feb 25, 2021
Maintains: Buy
Price Target: n/a
Current: $6.12
Upside: -
STRATA Skin Sciences
Nov 3, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.53
Upside: -
Avid Bioservices
Mar 11, 2020
Reiterates: Buy
Price Target: n/a
Current: $7.32
Upside: -
Soligenix
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.43
Upside: -
TG Therapeutics
Nov 14, 2017
Assumes: Buy
Price Target: n/a
Current: $13.91
Upside: -
Fortress Biotech
Jul 11, 2017
Initiates: Buy
Price Target: n/a
Current: $1.72
Upside: -
Pieris Pharmaceuticals
May 30, 2017
Initiates: Buy
Price Target: $720
Current: $11.60
Upside: +6,106.90%
Verastem
Mar 24, 2017
Reiterates: Buy
Price Target: n/a
Current: $9.22
Upside: -